CAS
CLOV icon

Coppell Advisory Solutions’s Clover Health Investments CLOV Stock Holding History

Coppell Advisory Solutions’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10
Closed -$9 – 1762
2023
Q3 		$9 Hold
10
– – ﹤0.01% 1191
2023
Q2 		$9 Buy
+10
New +$9 ﹤0.01% 1431
2023
Q1 		– Sell
-10
Closed -$9 – 360
2022
Q4 		$9 Buy
+10
New +$13 ﹤0.01% 1193

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Coppell Advisory Solutions's CLOV Position: Q4 2023 in Review

Coppell Advisory Solutions sold out of Clover Health Investments (CLOV) in Q4 2023, closing a stake of 10 shares — an estimated $9 sold.

Coppell Advisory Solutions first reported a position in CLOV in Q4 2022 and held it in 3 quarters. The position peaked at $9 in Q3 2023. 144 funds tracked by Wall St. Rank hold CLOV as of Q4 2023.

  • Coppell Advisory Solutions reported no remaining Clover Health Investments position as of Q4 2023 after selling out during the quarter.
  • Coppell Advisory Solutions sold 10 Clover Health Investments shares in Q4 2023, an estimated $9.
  • Coppell Advisory Solutions first reported a position in Clover Health Investments in Q4 2022 and held it in 3 quarters.
  • Coppell Advisory Solutions's Clover Health Investments position peaked at $9 in Q3 2023.
  • 144 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2023.

Based on Coppell Advisory Solutions's 13F filing for Q4 2023, filed 14 Feb 2024.